miR-197: A novel biomarker for cancers

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• MicroRNAs (miRNAs) are small noncoding RNAs regulating gene expression at the post-transcriptional level.
• miRNAs bind to the 3' untranslated region (3'UTR) of messenger RNAs (mRNAs), influencing protein production.
• Dysregulation of miRNAs is linked to the incidence and development of various neoplasms.

Purpose of the Study:

• To summarize the multifaceted roles of miR-197 in cancer.
• To explore miR-197's function as an oncogene or anti-oncogene in different cancer types.
• To evaluate miR-197 as a potential biomarker and therapeutic target in oncology.

Main Methods:

• Literature review of studies investigating miR-197 in various cancers.
• Analysis of miR-197's mechanisms of action in carcinogenesis.
• Compilation of data on miR-197's impact on apoptosis, proliferation, angiogenesis, metastasis, and drug resistance.

Main Results:

• miR-197 acts as either an oncogene or an anti-oncogene in different cancers by targeting key genes.
• miR-197 influences critical cancer progression pathways, including apoptosis, proliferation, angiogenesis, metastasis, and drug resistance.
• miR-197 has demonstrated a role in cancer prognosis.

Conclusions:

• miR-197 plays a significant role in various cancers, acting as both an oncogene and tumor suppressor.
• miR-197's involvement in diverse cancer mechanisms makes it a promising biomarker for cancer diagnosis and prognosis.
• Targeting miR-197 offers a potential strategy for novel molecular cancer therapies.